ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Alvotech
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$5.03+0.03 (+0.60%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 50.3
- Dividend yield
- –
Community
Notes and questions about Alvotech from other investors
No posts about ALVO yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.